World Journal of Nephrology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 28

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5015)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

189

HTML

2681

Sum=2870

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

313

Download

719

Sum=1032

Publishing Process of This Article

Item

Count

Browse

211

Download

692

Sum=903

Jul 28, 2024 (publication date) through May 5, 2026

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Qu B, Li Z. Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(28): 3447-3451 [PMID: 39091712 DOI: 10.3748/wjg.v30.i28.3447]
URL:	https://www.wjgnet.com/2220-6124/full/v30/i28/3447.htm

Number	Citing Articles
1	Gangfeng Zhu, Yipeng Song, Zenghong Lu, Qiang Yi, Rui Xu, Yi Xie, Shi Geng, Na Yang, Liangjian Zheng, Xiaofei Feng, Rui Zhu, Xiangcai Wang, Li Huang, Yi Xiang. Machine learning models for predicting metabolic dysfunction-associated steatotic liver disease prevalence using basic demographic and clinical characteristics. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06387-5
2	Anmol Singh, Aalam Sohal, Akash Batta. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(39): 4324-4328 doi: 10.3748/wjg.v30.i39.4324 Abstract(593) \| Core Tip(588) \| Full Article(HTML)(3366) \| Full Article with Cover (PDF)-637K(144) \| Audio-925K(7) \| Peer-Review Report-176K(107) \| Answering Reviewers-136K(103) \| Full Article (PDF)-378K(210) \| Full Article (XML)-76K(111) \| Times Cited (11) \| Total Visits (6396) \| Open
3	Juan Zhou, Min Liu, Jun Qiu, Wenxian Ouyang, Guanghui Zhu, Weijian Chen, Shuangjie Li, Hongmei Zhao. Diagnostic value of non-invasive indices for assessing liver fibrosis in Chinese children with metabolic dysfunction-associated steatotic liver disease. Frontiers in Pediatrics 2026; 13 doi: 10.3389/fped.2025.1694863
4	Yoshinori Ozeki, Takayuki Masaki, Nao Imaishi, Chiaki Yonezu, Machiko Morita, Yumi Mori, Takaaki Noguchi, Shotaro Miyamoto, Yuichi Yoshida, Koro Gotoh, Yuichi Endo, Masafumi Inomata, Hirotaka Shibata. Association Among Liver Enzymes, Liver-to-Spleen Hounsfield Unit Ratio, and Glycemic Profiles After Sleeve Gastrectomy in Diabetic and Non-Diabetic Japanese Patients with Obesity: A Retrospective Pilot Study. Livers 2026; 6(2): 26 doi: 10.3390/livers6020026
5	Davide Ramoni, Luca Liberale, Fabrizio Montecucco. Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(47): 5086-5091 doi: 10.3748/wjg.v30.i47.5086 Abstract(462) \| Core Tip(454) \| Full Article(HTML)(1935) \| Full Article with Cover (PDF)-597K(165) \| Audio-468K(6) \| Peer-Review Report-219K(93) \| Answering Reviewers-127K(102) \| Full Article (PDF)-397K(142) \| Full Article (XML)-89K(98) \| Times Cited (4) \| Total Visits (4654) \| Open
6	Kathryn Thompson, William Breaux, Lesley S. Miller, John Nemeth, Sarah Koumtouzoua, Natasha Travis. Effect of common diabetes medications on metabolic dysfunction-associated steatotic liver disease as measured by transient elastography and other metabolic parameters: A systematic review. Clinics and Research in Hepatology and Gastroenterology 2026; 50(3): 102784 doi: 10.1016/j.clinre.2026.102784
7	Bharath V Karnati, Pradip Kumar Behera, Krishna P Tripathy, Rama Sowmya Karanam, Aparajita Priyadarshini, Swati Das, Subhashree Mishra. Association and Diagnostic Performance of the Atherogenic Index of Plasma and Carotid Intima-Media Thickness in Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study. Cureus 2026; doi: 10.7759/cureus.105774
8	Toshifumi Yodoshi. Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2024; 30(47): 5070-5075 doi: 10.3748/wjg.v30.i47.5070 Abstract(509) \| Core Tip(485) \| Full Article(HTML)(2212) \| Full Article with Cover (PDF)-584K(219) \| Audio-267K(24) \| Peer-Review Report-215K(83) \| Answering Reviewers-186K(92) \| Full Article (PDF)-385K(153) \| Full Article (XML)-73K(133) \| Times Cited (8) \| Total Visits (6681) \| Open
9	Shengfang Liu, Qingjuan Zhang, Lijing Wang, Qin Tang, Bingtao Hu. MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1779292
10	Tobias Harm, Anne-Katrin Rohlfing, Jessica Kristin Henes, Nicole Manzat, Michal Droppa, Malte Bongers, Mathias Heikenwaelder, Karin Müller, Meinrad Gawaz, Dominik Rath. Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Inflammation Research 2025; : 11385 doi: 10.2147/JIR.S533707
11	Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang. Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1528732
12	Ke-Gong Xiong, Jin-Feng Kong, Tai-Shun Lin, Qing-Biao Lin, Kun-Yu Ke. Serum mir-181a as a potential serological biomarker for metabolic dysfunction-associated fatty liver disease: A cross sectional study. Medicine 2026; 105(4): e47290 doi: 10.1097/MD.0000000000047290